Cuban drug Heberprot-P authorized for medical trials in the US

Havana, May 4 (Prensa Latina) The authorization for the Cuban-made injectable drug Heberprot-P to begin phase three of clinical trials in the United States is a new achievement by Cuban scientists and researchers from the biotechnological and pharmaceutical industry.

Related Keywords

Caribe ,Sucre ,Venezuela ,United States ,Russia ,Cuba ,Colombia ,Cuban ,Charles Zelen ,Lee Weingart ,David Armstrong ,Marta Ayala ,Cuba Center ,University Of Southern California ,Drug Administration ,Good Diabetic Living Program ,Industries Business Group Biocubafarma ,Discovery Therapeutics Caribe ,Pharmaceutical Industries Business Group ,Genetic Engineering ,Prensa Latina ,Director Marta Ayala ,Southern California ,President Lee Weingart ,Podiatric Medicine ,